Patents by Inventor Mark David REKHTER

Mark David REKHTER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triazolopyrazinone derivative useful as a human PDE1 inhibitor
    Patent number: 10138244
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, for use as a human PDE1 inhibitor.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: November 27, 2018
    Assignee: Eli Lilly and Company
    Inventors: Mark David Rekhter, Qing Shi
  • PDE1 inhibitor
    Patent number: 10112951
    Abstract: The present invention provides a compound of Formula I: useful for treating chronic kidney disease and diabetic kidney disease.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: October 30, 2018
    Assignee: Eli Lilly and Company
    Inventor: Mark David Rekhter
  • PDE1 INHIBITOR
    Publication number: 20180099973
    Abstract: The present invention provides a compound of Formula I: useful for treating chronic kidney disease and diabetic kidney disease.
    Type: Application
    Filed: December 7, 2017
    Publication date: April 12, 2018
    Applicant: Eli Lilly and Company
    Inventor: Mark David REKHTER
  • TRIAZOLOPYRAZINONE DERIVATIVE USEFUL AS A HUMAN PDE1 INHIBITOR
    Publication number: 20180057494
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, for use as a human PDE1 inhibitor.
    Type: Application
    Filed: August 18, 2017
    Publication date: March 1, 2018
    Inventors: Mark David Rekhter, Qing Shi
  • 1,2-BENZOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF KIDNEY DISORDERS
    Publication number: 20170246166
    Abstract: The present invention provides 1,2-benzothiazole compounds particularly useful in the treatment of diabetic nephropathy and other chronic kidney disorders and other diabetic complications.
    Type: Application
    Filed: November 13, 2015
    Publication date: August 31, 2017
    Inventors: Michael James Genin, I, William Glen Holloway, Mark David Rekhter
  • PDE1 INHIBITOR
    Publication number: 20170233396
    Abstract: The present invention provides a compound of Formula I: useful for treating chronic kidney disease and diabetic kidney disease.
    Type: Application
    Filed: February 3, 2017
    Publication date: August 17, 2017
    Inventors: Cynthia Darshini JESUDASON, Mark David REKHTER